Sánchez Edith, Vargas Miguel Angel, Singru Praful S, Pascual Isel, Romero Fidelia, Fekete Csaba, Charli Jean-Louis, Lechan Ronald M
Tupper Research Institute and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center, 750 Washington Street, Boston, Massachusetts 02111, USA.
Endocrinology. 2009 May;150(5):2283-91. doi: 10.1210/en.2008-1643. Epub 2009 Jan 29.
Pyroglutamyl peptidase II (PPII), a highly specific membrane-bound metallopeptidase that inactivates TRH in the extracellular space, is tightly regulated by thyroid hormone in cells of the anterior pituitary. Whether PPII has any role in the region where axons containing hypophysiotropic TRH terminate, the median eminence, is unknown. For this purpose, we analyzed the cellular localization and regulation of PPII mRNA in the mediobasal hypothalamus in adult, male rats. PPII mRNA was localized in cells lining the floor and infralateral walls of the third ventricle and coexpressed with vimentin, establishing these cells as tanycytes. PPII mRNA extended in a linear fashion from the tanycyte cell bodies in the base of the third ventricle to its cytoplasmic and end-feet processes in the external zone of the median eminence in close apposition to pro-TRH-containing axon terminals. Compared with vehicle-treated, euthyroid controls, animals made thyrotoxic by the i.p. administration of 10 microg L-T(4) daily for 1-3 d, showed dramatically increased accumulation of silver grains in the mediobasal hypothalamus and an approximately 80% increase in enzymatic activity. PPII inhibition in mediobasal hypothalamic explants increased TRH secretion, whereas i.p. injection of a specific PPII inhibitor increased cold stress- and TRH-induced TSH levels in plasma. We propose that an increase in circulating thyroid hormone up-regulates PPII activity in tanycytes and enhances degradation of extracellular TRH in the median eminence through glial-axonal associations, contributing to the feedback regulation of thyroid hormone on anterior pituitary TSH secretion.
焦谷氨酸肽酶II(PPII)是一种高度特异性的膜结合金属肽酶,可在细胞外空间使促甲状腺激素释放激素(TRH)失活,它在前脑垂体细胞中受到甲状腺激素的严格调控。PPII在含有促垂体TRH的轴突终末所在区域——正中隆起中是否发挥作用尚不清楚。为此,我们分析了成年雄性大鼠中脑基底下丘脑PPII mRNA的细胞定位和调控情况。PPII mRNA定位于第三脑室底部和下外侧壁的衬里细胞中,并与波形蛋白共表达,确定这些细胞为伸长细胞。PPII mRNA以线性方式从第三脑室底部的伸长细胞体延伸至正中隆起外侧区的细胞质和终足突起,与含前体TRH的轴突终末紧密相邻。与给予赋形剂处理的甲状腺功能正常的对照动物相比,通过腹腔注射10微克L-T4,每日1 - 3天使动物产生甲状腺毒症,结果显示中脑基底下丘脑银颗粒积累显著增加,酶活性增加约80%。中脑基底下丘脑外植体中PPII的抑制增加了TRH的分泌,而腹腔注射特异性PPII抑制剂则增加了冷应激和TRH诱导的血浆促甲状腺激素(TSH)水平。我们提出,循环甲状腺激素的增加会上调伸长细胞中PPII的活性,并通过神经胶质-轴突联系增强正中隆起中细胞外TRH的降解,从而有助于甲状腺激素对垂体前叶TSH分泌的反馈调节。